| Understanding Ayurveda Disease Conditions and Treatment Responses (NCT06167226) | Ayurai Private Limited | 2021-12-29 |
| Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy (NCT04885751) | Seoul National University Boramae Hospital | 2021-06-01 |
| MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients) (NCT04724291) | George Washington University | 2021-02-10 |
| Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease (NCT03972956) | Renmin Hospital of Wuhan University | 2020-12-23 |
| Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy (NCT03609892) | Xijing Hospital of Digestive Diseases | 2018-08-01 |
| A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer (NCT03553563) | AstraZeneca | 2018-07-24 |
| Comparison Between Two Types of Sedation for Elective Upper Endoscopy Procedures (NCT04410211) | University of Malaya | 2018-06-01 |
| To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects (NCT03291418) | Antibe Therapeutics Inc. | 2017-09-08 |
| Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection (NCT03050307) | Takeda | 2017-04-17 |
| Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer (NCT02761512) | HK inno.N Corporation | 2016-05-01 |
| A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet (NCT02759224) | Boryung Pharmaceutical Co., Ltd | 2016-04-15 |
| A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection (NCT02689583) | First Affiliated Hospital of Zhejiang University | 2016-03-01 |
| A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA (NCT03057171) | Yonsei University | 2015-05-01 |
| Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin (NCT02423187) | Eisai Co., Ltd. | 2015-03-17 |
| Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases (NCT02219529) | Changhai Hospital | 2014-08-01 |
| BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects (NCT01964131) | AstraZeneca | 2013-10-01 |
| Remote-controlled Capsule Endoscopy: a Feasibility Study (NCT01946633) | Nanfang Hospital, Southern Medical University | 2013-10-01 |
| Nexium Capsules LDA Specific Clinical Experience Investigation (NCT01729182) | AstraZeneca | 2013-01-01 |
| A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers (NCT01762397) | PharmaKing | 2012-12-01 |
| Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation (NCT01562600) | AstraZeneca | 2012-04-19 |
| A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy (NCT01568385) | Takeda | 2012-04-01 |
| Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer (NCT01452711) | Takeda | 2011-11-01 |
| Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation (NCT01435525) | AstraZeneca | 2011-09-01 |
| Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation (NCT01150162) | Otsuka Pakistan Limited | 2010-10-01 |
| Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer (NCT01190657) | Eisai Co., Ltd. | 2010-05-01 |
| A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers (NCT00961350) | POZEN | 2009-10-01 |
| Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets (NCT01037491) | Taipei Veterans General Hospital, Taiwan | 2009-10-01 |
| Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers (NCT00960869) | POZEN | 2009-10-01 |
| Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec (NCT00594854) | POZEN | 2007-09-01 |
| Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen (NCT00527787) | POZEN | 2007-09-01 |
| Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID (NCT00542789) | AstraZeneca | 2007-08-01 |
| A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO) (NCT00527904) | POZEN | 2007-03-01 |
| Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) (NCT00441727) | AstraZeneca | 2007-02-01 |
| An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium (NCT00428701) | AstraZeneca | 2006-10-01 |
| Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric Ulcer (NCT00401752) | AstraZeneca | 2006-03-01 |
| Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection (NCT00197418) | Hamamatsu University | 2003-08-01 |
| Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori (NCT00149084) | Hamamatsu University | 2003-04-01 |
| Pepsinogens as the Early Marker of H. Pylori Eradication (NCT00197457) | Hamamatsu University | 2001-06-01 |
| Effect of Selective COX-2 Inhibition on Ulcer Healing (NCT00153673) | Chinese University of Hong Kong | 2001-02-01 |
| Helicobacter Pylori Eradication With a New Sequential Treatment (NCT00132171) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2001-01-01 |
| Lymphocytic Subsets and Cytokine Production With H. Pylori Infection (NCT00173953) | National Taiwan University Hospital | 2001-01-01 |
| Cytokine Gene Polymorphisms in Gastric Diseases (NCT00197470) | Hamamatsu University | 2000-01-01 |
| Safety of Rabeprazole in Patients Under Multiple Treatments (NCT00511745) | Janssen-Cilag, S.A. | |